PAMELA SCHWARTZ: Open Payments
NPI 1679639942 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 10 payments from 6 companies in 2025. Trend: 2023 $149 · 2024 $151 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Alkermes, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
Products named: REXULTI, CAPLYTA, COBENFY, ARISTADA, INGREZZA, ABILIFY MAINTENA.
Industry payments across IN — which companies pay providers there.
